Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-209.61%
operating margin TTM
-247.82%
revenue TTM
6.65 Million
revenue per share TTM
0.25$
valuation ratios | |
|---|---|
| pe ratio | -1.26 |
| peg ratio | -0.05 |
| price to book ratio | 1.14 |
| price to sales ratio | 2.59 |
| enterprise value multiple | -2.59 |
| price fair value | 1.14 |
profitability ratios | |
|---|---|
| gross profit margin | 98.1% |
| operating profit margin | -247.82% |
| pretax profit margin | -204.35% |
| net profit margin | -209.61% |
| return on assets | -31.07% |
| return on equity | -65.11% |
| return on capital employed | -47.26% |
liquidity ratio | |
|---|---|
| current ratio | 4.40 |
| quick ratio | 4.40 |
| cash ratio | 1.94 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 4,357.59 |
| cash conversion cycle | -4,357.59 |
| receivables turnover | 0.00 |
| payables turnover | 0.08 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.07 |
| debt equity ratio | 0.19 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.16 |
| interest coverage | -57.66 |
| cash flow to debt ratio | -3.70 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.73 |
| cash per share | 2.86 |
| operating cash flow per share | -0.73 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -3.70 |
| short term coverage ratios | -4.00 |
| capital expenditure coverage ratio | -849.74 |
Frequently Asked Questions
When was the last time LAVA Therapeutics N.V. (NASDAQ:LVTX) reported earnings?
LAVA Therapeutics N.V. (LVTX) published its most recent earnings results on 10-12-2024.
What is LAVA Therapeutics N.V.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. LAVA Therapeutics N.V. (NASDAQ:LVTX)'s trailing twelve months ROE is -65.11%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. LAVA Therapeutics N.V. (LVTX) currently has a ROA of -31.07%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did LVTX's net profit margin stand at?
LVTX reported a profit margin of -209.61% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is LVTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.40 in the most recent quarter. The quick ratio stood at 4.40, with a Debt/Eq ratio of 0.19.